Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on C Acid. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel glucose-based route for triazole intermediates. Reduces cost and improves supply chain reliability for pharmaceutical manufacturing processes globally.
Patent CN110452150A reveals a novel synthesis route. Offers high optical purity and mild conditions for reliable chiral pharmaceutical intermediate supply chains.
Patent CN111848322B details a chiral phosphoric acid catalyzed resolution method for axially chiral oxindole-styrenes, offering high enantioselectivity and mild conditions for pharmaceutical intermediate manufacturing.
Novel chiral phosphoric acid catalysis for indolocyclopentanes. High yield, mild conditions, scalable for pharma intermediates. Reliable supply chain solutions.
Novel chiral phosphoric acid catalysis enables high yield synthesis. Offers cost reduction and supply chain reliability for pharmaceutical intermediates.
Patent CN115850216B reveals Rh-catalyzed route. Green water solvent ensures high purity and supply chain stability for global buyers.
Novel Ag-catalyzed route for 9,10-phenanthrene dicarboxylic esters offers mild conditions and high purity for reliable pharmaceutical intermediate supply chains.
Patent CN111848322B details a novel chiral phosphoric acid catalyzed resolution for axially chiral oxindole-substituted styrenes, offering high enantioselectivity and mild conditions for pharmaceutical intermediate manufacturing.
Novel chiral induction method for Paxlovid intermediate. Reduces cost and improves safety. Reliable supply chain partner for pharmaceutical manufacturing.
Patent CN116023359A reveals a breakthrough copper-catalyzed amination route for aminothiophenes, offering superior yields and safety over traditional nitration for pharmaceutical supply chains.
Patent CN116199614B reveals high ee synthesis. Offers cost reduction and supply reliability for pharmaceutical intermediates manufacturing.
Novel 4-step process for high-purity intermediates. Reduces complexity and enhances supply chain reliability for global manufacturers.
Novel chiral synthesis method offers high yield and enantioselectivity for antitumor drug intermediates, ensuring supply chain stability.
Novel 5 5 tetralone skeleton chiral phosphoric acid patent CN105111228A offers enhanced acidity and enantioselectivity for pharmaceutical intermediates with cost effective synthesis
Novel chiral phosphoric acid catalyzed method for high-purity tetrahydroacridines. Reduces steps and improves enantioselectivity for pharma intermediates.
Novel axial chiral indole-furan catalyst patent CN117720537B enables mild asymmetric synthesis. Offers high enantioselectivity and cost-effective manufacturing for reliable pharma intermediate supply chains.
Novel chiral phosphoric acid catalyzed synthesis of N-N axis pyrroles. High yield, mild conditions, suitable for pharmaceutical intermediate manufacturing.
Novel chiral phosphoric acid catalysis for indolocyclopentanes. High yield, scalable process for anticancer drug development. Reliable supply chain partner.
Patent CN112679498A reveals a high-purity route for beta-lactamase inhibitors, offering significant cost and supply chain advantages for API manufacturers.
Advanced synthesis method for Oseltamivir phosphate isomer impurity ensuring quality control. Reliable supplier for pharmaceutical intermediates with cost reduction.